George Tetz

George Tetz

Company: CLS Therapeutics & The Human Microbiology Institute

Job title: Chief Executive Officer

Seminars:

Uncovering Microbiome-Derived Therapeutic Targets to Treat Alzheimer’s Disease 11:30 am

Investigating Alzheimer’s disease in the context of the microbiome: what do biopharma need to know? Analyzing how microbial DNAs involvement in Alzheimer’s disease can be exploited as a treatment strategy against it  Revealing how DNA of some species triggers protein misfolding and learning how this influences Alzheimer’s development and progressionRead more

day: Track A - Day 2

Weaponizing the Microbiome Against Alzheimer’s Disease 8:00 am

Investigating Alzheimer’s disease in the context of the microbiome: what do biopharma need to know? Analyzing how microbial DNAs involvement in Alzheimer’s disease can be exploited as a treatment strategy against it Revealing how DNA of some species triggers protein misfolding and learning how this influences Alzheimer’s development and progressionRead more

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.